GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 180 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q1 2018. The put-call ratio across all filers is 0.55 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,275,000 | +513.0% | 18,720 | +164.0% | 0.00% | – |
| Q4 2021 | $208,000 | -51.4% | 7,091 | -45.8% | 0.00% | -100.0% |
| Q2 2021 | $428,000 | +84.5% | 13,080 | +130.1% | 0.00% | – |
| Q1 2021 | $232,000 | -14.4% | 5,684 | -10.0% | 0.00% | – |
| Q4 2020 | $271,000 | -16.9% | 6,313 | +5.7% | 0.00% | -100.0% |
| Q3 2020 | $326,000 | -85.4% | 5,974 | -83.1% | 0.00% | -75.0% |
| Q2 2020 | $2,231,000 | +13.1% | 35,344 | -8.4% | 0.00% | +33.3% |
| Q1 2020 | $1,972,000 | +24.0% | 38,599 | +93.0% | 0.00% | +50.0% |
| Q4 2019 | $1,590,000 | +109.5% | 20,003 | +27.9% | 0.00% | +100.0% |
| Q3 2019 | $759,000 | +22.2% | 15,643 | +32.5% | 0.00% | 0.0% |
| Q2 2019 | $621,000 | +80.5% | 11,807 | +40.7% | 0.00% | – |
| Q4 2018 | $344,000 | -54.3% | 8,390 | -57.6% | 0.00% | -100.0% |
| Q3 2018 | $753,000 | -12.8% | 19,806 | +3.7% | 0.00% | 0.0% |
| Q2 2018 | $864,000 | -33.6% | 19,108 | -29.1% | 0.00% | 0.0% |
| Q1 2018 | $1,302,000 | +54.1% | 26,963 | +25.5% | 0.00% | 0.0% |
| Q4 2017 | $845,000 | +59.1% | 21,476 | +25.5% | 0.00% | 0.0% |
| Q3 2017 | $531,000 | +35.5% | 17,114 | +19.5% | 0.00% | 0.0% |
| Q2 2017 | $392,000 | +95.0% | 14,323 | +163.2% | 0.00% | – |
| Q1 2017 | $201,000 | – | 5,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 356,270 | $24,262,000 | 23.36% |
| Twin Securities, Inc. | 376,669 | $25,651,000 | 11.94% |
| Paradigm Biocapital Advisors LP | 1,175,879 | $80,077,000 | 10.68% |
| Chicago Capital Management, LLC | 246,246 | $16,769,000 | 9.12% |
| HARVEST MANAGEMENT LLC | 141,500 | $9,636,000 | 7.78% |
| Fernwood Investment Management, LLC | 174,724 | $11,899,000 | 5.02% |
| ArchPoint Investors | 168,725 | $11,490,000 | 4.69% |
| HAVENS ADVISORS LLC | 46,000 | $3,133,000 | 4.69% |
| Perceptive Advisors | 2,322,247 | $158,145,000 | 4.59% |
| Crabel Capital Management, LLC | 112,680 | $7,674,000 | 4.48% |